loadpatents
name:-0.0092699527740479
name:-0.0064470767974854
name:-0.004486083984375
Pohl; Oliver Patent Filings

Pohl; Oliver

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pohl; Oliver.The latest application filed is for "oral formulations of pyrrolidine derivatives".

Company Profile
4.4.8
  • Pohl; Oliver - Plan-les-Ouates CH
  • Pohl; Oliver - Archamps FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oral formulations of pyrrolidine derivatives
Grant 11,419,851 - Chollet , et al. August 23, 2
2022-08-23
Oral Formulations Of Pyrrolidine Derivatives
App 20200281892 - CHOLLET; Andre ;   et al.
2020-09-10
Gonadotropin-releasing Hormone Antagonist Dosing Regimens For Treating Uterine Fibroids And Reducing Menstrual Blood Loss
App 20200179390 - LOUMAYE; Ernest ;   et al.
2020-06-11
Alpha-amino Esters Of Hydroxypropylthiazolidine Carboxamide Derivative And Salt Form, Crystal Polymorph Thereof
App 20200155515 - PAGE; Patrick Naxos ;   et al.
2020-05-21
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
Grant 10,555,934 - Page , et al. Feb
2020-02-11
Oral formulations of pyrrolidine derivatives
Grant 10,478,420 - Chollet , et al. Nov
2019-11-19
Alpha-amino Esters Of Hydroxypropylthiazolidine Carboxamide Derivative And Salt Form, Crystal Polymorph Thereof
App 20190000812 - PAGE; Patrick Naxos ;   et al.
2019-01-03
Oral Formulations Of Pyrrolidine Derivatives
App 20180311211 - CHOLLET; Andre ;   et al.
2018-11-01
Oral formulations of pyrrolidine derivatives
Grant 9,962,367 - Chollet , et al. May 8, 2
2018-05-08
Progesterone Receptor Modulators for Use in Preventing or Treating Androgen Mediated Diseases
App 20150209373 - Pohl; Oliver ;   et al.
2015-07-30
Oral Formulations Of Pyrrolidine Derivatives
App 20150164859 - CHOLLET; Andre ;   et al.
2015-06-18
Steroid Sulfatase Inhibitor Regimen for the Treatment of Endometriosis
App 20150065470 - Loumaye; Ernest ;   et al.
2015-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed